Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

378

Citations

25

References

2017

Year

Toshihiro Kudo, Yasuo Hamamoto, Ken Kato, Takashi Ura, Takashi Kojima, Takahiro Tsushima, Shuichi Hironaka, Hiroki Hara, Taroh Satoh, Satoru Iwasa,

The Lancet Oncology

Surgical OncologyEsophageal CancerNivolumab TreatmentGastrointestinal OncologyMedicineSurgeryOesophageal Squamous-cell CarcinomaCancer TreatmentPhase 2OncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1